MN Sirott, DF Bajorin, GYC Wong, Y Tao, … - CA A Cancer Journal for Clinicians - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 157 - Related articles - BL Direct - All 3 versions
A Vigano, E Bruera, GS Jhangri, SC Newman, … - Archives of Internal Medicine, 2000 - archinte.highwire.org You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Add to CiteULike Add to ... Cited by 123 - Related articles - BL Direct - All 4 versions
RF Schneider, K Seibert, S Passe, C Little, T … - CA A Cancer Journal for Clinicians - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 77 - Related articles - All 2 versions
G Bacci, P Picci, S Ferrari, M Mercuri, AB del … - CA A Cancer Journal for Clinicians - interscience.wiley.com Ifosfamide (IF) alone or combined with etoposide (ET) was reported to be
effective in the treatment of patients with Ewing's sarcoma who relapsed after
treatment with the VACA regimen, which consisted of vincristine (VC), ... Cited by 64 - Related articles - BL Direct - All 4 versions
GF Buccheri, B Violante, AM Sartoris, D … - CA A Cancer Journal for Clinicians - interscience.wiley.com In 98 newly diagnosed patients with histologically proven bronchogenic carcinoma
seen at Cuneo Hospital of Chest Diseases from July 1983 to December 1984,
multiple biomarker assays were performed. Fifty-nine cases had more than ... Cited by 63 - Related articles - All 4 versions
DL Glaubiger, R Makuch, J Schwarz, AS … - CA A Cancer Journal for Clinicians - interscience.wiley.com We have analyzed the results of treatment of 117 patients with Ewing's sarcoma
admitted to the National Cancer Institute since 1964. All patients received
local irradiation to the primary site and a series of progressively more ... Cited by 54 - Related articles - All 2 versions
- ►ascopubs.org [PDF] U Sagman, R Feld, WK Evans, D Warr, FA … - Journal of Clinical Oncology, 1991 - jco.ascopubs.org THE SURVIVAL of patients with small-cell carcinoma of the lung (SCLC) has
improved with the advent of new chemotherapeutic agents and the use of
combination chemotherapy.' With- out treatment, the median length of ... Cited by 49 - Related articles - All 6 versions
RW Makuch - Journal of Chronic Diseases, 1982 - Elsevier Covariate adjustment techniques, such as Cox's proportional hazard model, are
used frequently in the analysis of clinical trials to compare survival of
patients in two or more treatment groups. A visual display of survival ... Cited by 42 - Related articles - All 4 versions
T Encan, E Hannisdal - Acta Oncologica, 1990 - informahealthcare.com Knowledge of prognostic factors is necessary both in planning and comparing
cancer treatment regimens. In primary lung cancer initial performance status,
extent of disease and weight loss are well-known prognostic factors for ... Cited by 39 - Related articles - All 5 versions
DL Glaubiger, RW Makuch, J Schwarz - National Cancer Institute monograph, 1981 - ncbi.nlm.nih.gov We have analyzed the survival data for 117 patients with Ewing's sarcoma treated
at the National Cancer Institute since 1964. Treatment consisted of local
irradiation to the primary site and a series of increasingly intensive ... Cited by 25 - Related articles - All 2 versions
